← All patents

US20200157637A1

Targeting of anaplastic lymphoma kinase in squamous cell carcinoma

University of Texas System

Abstract

Methods for identifying patients with high risk (progression, invasion, metastasis) squamous cell carcinoma using methylation and/or expression assays are disclosed. Also provided are methods of treating such high risk cancers with ALK inhibitors combined with anti-EGFR based therapies, as the …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Cara B. GONZALES
Priority date
May 26, 2017
Filing date
May 23, 2018
Publication date
May 21, 2020
Language
en
Metadata fetched
August 29, 2026 00:27